In English
NIDA

Investigaciones sobre los tratamientos

Four Scientists Receive Avant-Garde Awards

Recognizes four scientists for the 2009 Avant-Garde Award for HIV research, an award intended to stimulate groundbreaking research for the prevention and treatment of HIV/AIDS in drug abusers.

Young Opioid Abusers Benefit From Extended Buprenorphine-Naloxone Treatment

Reports on a study investigating the benefits of extended opioid maintenance therapy that included drug counseling and 12 weeks of therapy with buprenorphine and naloxone.

Stroop Test Identifies Patients at Risk for Treatment Dropout

Reports on a study of cocaine abusers revealing that the Stroop test may predict which cocaine abusers are likely to drop out of therapy.

Helping Doctors Become First Responders to Substance Abuse

NIDA Director Nora Volkow

Describes a toolkit that guides doctors in assessing a patient’s risk of developing an addiction problem, advising patients on the effects of substance abuse, and arranging for referrals.

James A. Inciardi (1939-2009)

Remembers Dr. James A. Inciardi, founder and co-director of the Center for Drug and Alcohol Studies and professor at the University of Delaware, who died on November 23, 2009.

Dr. Phil Skolnick Now Leads NIDA's Medications Development Efforts

Announces the appointment of Dr. Phil Skolnick as NIDA’s director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse.

Attention to Bipolar Disorder Strengthens Substance Abuse Treatment

Describes a study of participants who had both substance abuse and bipolar disorder to investigate the potential benefits of integrated group therapy for this population.

NIDA Launches Criminal Justice Publication in Chicago

Highlights a publication that outlines 13 research-based principles of successful treatment of drug abusers in the criminal justice system.

Study Finds Withdrawal No Easier With Ultrarapid Opiate Detox

Presents findings from a clinical trial comparing ultrarapid, anesthesia-assisted detoxification with detoxification by traditional methods among patients addicted to heroin.

First-time Patients Opt for Office-Based Buprenorphine

Presents highlights of a study suggesting that compared with methadone, office-based buprenorphine treatment attracts individuals who have less extensive addiction histories.

Páginas

Take the IQ Challenge en Español!